胰岛素样生长因子-1对早产儿脑白质损伤的保护作用及其机制

马红芳; 薛江; 梁爽

doi:10.11852/zgetbjzz2022-1285

PDF(2018 KB)

中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (11) : 1219-1224. DOI: 10.11852/zgetbjzz2022-1285

综述

胰岛素样生长因子-1对早产儿脑白质损伤的保护作用及其机制

马红芳, 薛江, 梁爽

作者信息 +

Protective effect and mechanism of insulin-like growth factor 1 in preterm infants with white matter damage

MA Hongfang, XUE Jiang, LIANG Shuang

Author information +

文章历史 +

摘要

脑白质损伤(WMD)作为一种脱髓鞘疾病,发病机制及损伤形式多样、治疗手段有限,是目前早产儿发生情感障碍、认知障碍、感知觉障碍等神经系统后遗症的重要原因。据报道,WMD的上游事件对髓鞘的损害可能与胰岛素样生长因子1(IGF-1)水平的微调相关。IGF-1作为神经营养因子不仅可以促进WMD时少突胶质细胞(OLs)的发育、髓鞘的成熟,甚至可以逆转WMD带来的神经行为异常。鉴于此,现就IGF-1对WMD的保护作用及其机制等研究进展进行综述。

Abstract

White matter damage (WMD) in preterm infants, as a demyelinating disease, has a variety of pathogenesis and forms of damage. Due to the lack of specific treatment, it is the main cause of long-term sequelae such asperceptual disability, cognitive impairment and emotional disorder in preterm infants. Ithas been reported that the fine-tuning of insulin-like growth factor-1(IGF-1) levels by upstream events of WMD may lead to myelination disorders, and targeted supplementation of recombinant human insulin-like growth factor-1(rh-IGF-1) can not only promote the development of oligodendrocytes(OLs) and myelin maturation in WMD, but also reverse the neurobehavioral abnormalities caused by WMD. In view of this, this article reviews the progress of IGF-1 in WMD.

导出引用

马红芳, 薛江, 梁爽. 胰岛素样生长因子-1对早产儿脑白质损伤的保护作用及其机制[J]. 中国儿童保健杂志. 2023, 31(11): 1219-1224 https://doi.org/10.11852/zgetbjzz2022-1285

MA Hongfang, XUE Jiang, LIANG Shuang. Protective effect and mechanism of insulin-like growth factor 1 in preterm infants with white matter damage[J]. Chinese Journal of Child Health Care. 2023, 31(11): 1219-1224 https://doi.org/10.11852/zgetbjzz2022-1285

中图分类号： R722.6

参考文献

[1] Walani S R.Global burden of preterm birth[J].Int J Gynaecol Obstet, 2020, 150(1):31-33.
[2] Back SA.White matter injury in the preterm infant:pathology and mechanisms[J].Acta Neuropathol, 2017, 134(3):331-349.
[3] Panfoli I, Candiano G, Malova M, et al.Oxidative stress as a primary risk factor for brain damage in preterm newborns[J].Front Pediatr, 2018, 6:369.
[4] Guillen N, Llerena C, Samalvides S, et al.Risk of brain damage in premature infants under 34 weeks of gestational age exposed to histological chorioamnionitis Lima, peru[J].Rev Peru Med Exp Salud Publica, 2020, 37(2):229-238.
[5] Huang X, Fu J.Associationbetween assisted reproductive technology and white matter injury in premature infants:a case-control study[J].Front Pediatr, 2021, 9:686670.
[6] 岳艳,张莉,屈艺,等.少突胶质前体细胞移植对早产儿脑白质损伤的保护作用[J].中国当代儿科杂志,2018,20(4):326-331.
Yue Y, Zhang L, Qu Y, et al.Neuroprotective effects of oligodendrocyte precursor cells on white matter damage in preterm infants[J].Chin J Contemp Pediatr, 2018, 20(4):326-331.(in Chinese)
[7] Cai C, Ahmad T, Valencia GB, et al.Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver[J].Growth Horm IGF Res, 2018, 41:54-63.
[8] Forbes BE, Blyth AJ, Wit JM.Disorders of IGFs and IGF-1R signaling pathways[J].Mol Cell Endocrinol, 2020, 518:111035.
[9] Hellstrom W, Hortensius LM, Lofqvist C, et al.Postnatal serum IGF-1 levels associate with brain volumes at term in extremely preterm infants[J].Pediatr Res, 2022.
[10] Torres-Cuevas I, Corral-Debrinski M, Gressens P.Brain oxidative damage in murine models of neonatal hypoxia/ischemia and reoxygenation[J].Free Radic Biol Med, 2019, 142:3-15.
[11] Janowska J,Gargas J, Ziemka-Nalecz M, et al.Oligodendrocyte response to pathophysiological conditions triggered by episode of perinatal hypoxia-ischemia:Role of IGF-1 secretion by glial cells[J].Mol Neurobiol, 2020, 57(10):4250-4268.
[12] Zhou J, Terluk MR, Basso L, et al.N-acetylcysteine provides cytoprotection in murine oligodendrocytes through heme oxygenase-1 activity[J].Biomedicines, 2020, 8(8):240.
[13] Fern R, Matute C.Glutamate receptors and white matter stroke[J].Neurosci Lett, 2019, 694:86-92.
[14] Ness JK, Scaduto RC Jr, Wood TL.IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4⁺ oligodendrocyte progenitors[J].Glia, 2004, 46(2):183-194.
[15] Simonishvili S, Jain MR, Li H, et al.Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia[J].ASN Neuro, 2013, 5(5):e00131.
[16] Zhao B, Zheng Z.Insulingrowth factor 1 protects neural stem cells against apoptosis induced by hypoxia through Akt/mitogen-activated protein Kinase/extracellular signal-regulated kinase (Akt/MAPK/ERK) pathway in hypoxia-ishchemic encephalopathy[J].Med Sci Monit, 2017, 23:1872-1879.
[17] Shao R, Sun D, Hu Y, et al.White matter injury in the neonatal hypoxic-ischemic brain and potential therapies targeting microglia[J].J Neurosci Res, 2021, 99(4):991-1008.
[18] Pierre WC, Londono I, Quiniou C, et al.Modulatory effect of IL-1 inhibition following lipopolysaccharide-induced neuroinflammation in neonatal microglia and astrocytes[J].Int J Dev Neurosci, 2022, 82(3):243-260.
[19] Goshi N, Morgan RK, Lein PJ, et al.A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation[J].J Neuroinflammation, 2020, 17(1):155.
[20] Pinto-Benito D, Paradela-Leal C, Ganchala D, et al.IGF-1 regulates astrocytic phagocytosis and inflammation through the p110alpha isoform of PI3K in a sex-specific manner[J].Glia, 2022, 70(6):1153-1169.
[21] Zhou Y, Zhang J, Wang L, et al.Interleukin-1beta impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion[J].Brain Behav Immun, 2017, 60:93-105.
[22] Klevebro S, Hellgren G, Hansen-Pupp I, et al.Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants[J].Growth Horm IGF Res, 2020, 50:1-8.
[23] Liddelow SA, Guttenplan KA, Clarke LE, et al.Neurotoxic reactive astrocytes are induced by activated microglia[J].Nature, 2017, 541(7638):481-487.
[24] Breton JM, Long KLP, Barraza MK, et al.Hormonalregulation of oligodendrogenesis Ⅱ:Implications for myelin repair[J].Biomolecules, 2021, 11(2):290.
[25] Li QY, Miao Q, Sui RX, et al.Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis[J].Int Immunopharmacol, 2019, 75:105819.
[26] Shi B, Ding J, Liu Y, et al.ERK1/2 pathway-mediated differentiation of IGF-1-transfected spinal cord-derived neural stem cells into oligodendrocytes[J].PLoS One,2014, 9(8):e106038.
[27] Lorenzati M, Boda E, Parolisi R, et al.c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination[J].Sci Rep, 2021, 11(1):7264.
[28] Min J, Singh S, Fitzgerald-Bocarsly P, et al. Insulin-like growth factor Ⅰ regulates G2/M progression through mammalian target of rapamycin signaling in oligodendrocyte progenitors[J]. Glia,2012,60(11):1684-95.
[29] Bibollet-Bahena O, Almazan G.IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways[J].J Neurochem, 2009, 109(5):1440-1451.
[30] Gonsalvez D, Ferner AH, Peckham H, et al.The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination[J].Neuropharmacology, 2016, 110(Pt B):586-593.
[31] Ishii A, Furusho M, Macklin W, et al.Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood[J].Glia, 2019, 67(7):1277-1295.
[32] Wang H, Liu M, Ye Z, et al.Akt regulates sox10 expression to control oligodendrocyte differentiation via phosphorylating FoxO1[J].J Neurosci, 2021, 41(39):8163-8180.
[33] Srivastava T, Diba P, Dean JM, et al.A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors[J].J Clin Invest, 2018, 128(5):2025-2041.
[34] Liu X, Dong C, Liu K, et al.mTOR pathway repressing expression of FoxO3 is a potential mechanism involved in neonatal white matter dysplasia[J].Hum Mol Genet, 2022, 31(15):2508-2520.
[35] Watamoto Y, Futawaka K, Hayashi M, et al.IGF-1 regulate the expression of uncoupling protein 2 via FOXO1[J].Growth Factors, 2019, 37(5-6):247-256.
[36] Lin KN, Zhang K, Zhao W, et al.Insulin-like growth factor 1 promotes cell proliferation by downregulation of G-Protein-Coupled receptor 17 expression via PI3K/Akt/FoxO1 signaling in SK-N-SH cells[J].Int J Mol Sci, 2022, 23(3):1513.
[37] Vaes JEG, Kosmeijer CM, Kaal M, et al.Regenerative therapies to restore interneuron disturbances in experimental models of encephalopathy of prematurity[J].Int J Mol Sci, 2020, 22(1):211.
[38] Tien LT, Lee YJ, Pang Y, et al.Neuroprotective effects of intranasal IGF-1 against neonatal lipopolysaccharide-induced neurobehavioral deficits and neuronal inflammation in the substantia nigra and locus coeruleus of juvenile rats[J].Dev Neurosci, 2017, 39(6):443-459.
[39] Chung JK,Hallberg B,Hansen-Pupp I,et al.Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants[J].Pediatr Res, 2017, 81(3):504-510.
[40] Hellstrom A, Ley D, Hallberg B, et al.IGF-1 as a drug for preterm infants:A step-wise clinical development[J].Curr Pharm Des, 2017, 23(38):5964-5970.
[41] Lin S, Fan L-W, Pang Y, et al. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Research, 2005, 1063(1): 15-26.
[42] Lin S, Fan LW, Rhodes PG, et al. Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats[J]. Experimental neurology, 2009, 217(2): 361-370.
[43] Hellgren G, Han W, Wang X, et al. Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice[J]. Growth Horm IGF Res, 2011, 21(4):205-211.
[44] Gram M,Ekstrom C, Holmqvist B, et al. Insulin-like growth factor 1 in the preterm rabbit pup:Characterization of cerebrovascular maturation following administration of recombinant human insulin-like growth factor 1/insulin-like growth factor 1-binding protein 3[J]. Dev Neurosci, 2021, 43(5):281-295.
[45] Kalimuthu S, Oh JM, Gangadaran P, et al.Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer[J].PLoS One, 2017, 12(7):e0181318.
[46] Vaes JEG, Van Kammen CM, Trayford C, et al.Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity[J].Glia, 2021, 69(3):655-680.
[47] Chen S, Wang T, Yao J, et al.Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo:Therapeutic implication for alzheimer′s disease[J].Neurotherapeutics, 2020, 17(4):1813-1824.
[48] Gyetvai G, Hughes T, Wedmore F,et al.Erythropoietin increases myelination in oligodendrocytes:Gene expression profiling reveals early induction of genes involved in lipid transport and metabolism[J].Front Immunol, 2017, 8:1394.
[49] Steinman G, Mankuta D.Molecular biology of autism′s etiology-an alternative mechanism[J].Med Hypotheses, 2019, 130:109272.